Filter

51 - 60 of 94 Results

  • PEPFAR Reauthorization on the Horizon

    Perspective

    In this Think Global opinion piece, Jennifer Kates and Kellie Moss discuss what could happen if the United States’ signature initiative on global health is not reauthorized.

  • PEPFAR Reauthorization 2023: Key Issues

    Policy Watch

    This year, Congress will consider reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR). This Policy Watch provides fast facts about the program and top issues related to its authorization and funding.

  • Testimony: The U.S. Government Role in Women’s Global Health and Key Challenges

    Issue Brief

    Jennifer Kates, Senior Vice President and Director of KFF’s Global Health & HIV Policy program, testified before the U.S. House of Representatives’ Committee on Foreign Affairs as part of a hearing on Unique Challenges Women Face in Global Health. Her testimony describes the role of the U.S. government in women’s global health and highlights challenges and opportunities to strengthen these efforts.

  • The U.S. Government and Multilateral Global Health Engagement: 5 Key Facts

    Issue Brief

    With ongoing questions about future U.S. support for multilateral health efforts as well as important markers on the near horizon, including donor replenishment conferences for both the Global Fund and Gavi within the next two years, this brief highlights five key facts about U.S. engagement with multilateral global health organizations.

  • COVID-19 & PEPFAR: Implications for the Future

    Issue Brief

    The potential for the COVID-19 pandemic to significantly affect the health and development of low- and middle-income countries (LMICs), particularly those in sub-Saharan Africa, has serious implications for PEPFAR, the President’s Emergency Plan for AIDS Relief (PEPFAR). This issue brief examines the steps PEPFAR has taken to respond to the outbreak and the issues at stake.

  • Reading the Tea Leaves on U.S. Global Health Policy

    Perspective

    In this Policy Insight, Jen Kates and Josh Michaud look at the prospects for the future of U.S. global health policy, examining whether long-term bipartisan support may be tested during a time of political transition, and identifying key areas of consensus among policymakers and the public.

  • The U.S. Global Health Budget: Analysis of Appropriations for Fiscal Year 2016

    Issue Brief

    After Congress provided an unprecedented level of emergency funding for Ebola in FY15 in response to the West African outbreak, beyond regular appropriations for global health programs, FY16 returned to business as usual. There was no additional emergency funding and global health amounts remained essentially flat funding compared to prior years. The FY16 Omnibus Appropriations bill, which was signed into law by the President on December 18, 2015, included an estimated $10.2 billion in funding for global health programs continuing a trend of essentially flat funding since FY10.